Back

Prevalence of diastolic dysfunction according to 2016 ASE/EACVI criteria in non-dialysis chronic kidney disease patients

10 May 2026 (11:30 - 12:15)
Organised by: Logo
Congress Presentation Part of: Advanced pharmacotherapy in complex heart failure scenarios Comorbidities Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Associate Professor Selda Murat

Eskisehir Osmangazi University, Eskisehir (Turkiye)

6 More presentations in this session

Presentation thumbnail
Efficacy and safety of sacubitril-valsartan versus enalapril in patients with heart failure due to Chagas cardiomyopathy: a systematic review and meta-analysis
Doctor B. Aziri (Sarajevo, BA)
Abstract Slides Video
Presentation thumbnail
Improved subgroup treatment effect estimation in heart failure trials using Bayesian hierarchical shrinkage models
Doctor A. Henderson (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Sacubitril/valsartan, initial dip in estimated glomerular filtration rate, and clinical outcomes in patients with heart failure
Doctor M. Manabe (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Guideline directed medical therapy in patients with heart failure with reduced ejection fraction undergoing renal replacement therapy: real world experience from a specialized cardiorenal unit
Doctor S. Ruiz Bustillo (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Effect of sacubitril/valsartan and SGLT2 inhibitors on echocardiographic response and clinical outcomes after cardiac resynchronization therapy: insights from a real-world cohort
Doctor I. Martins Moreira (Vila Real, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Advanced pharmacotherapy in complex heart failure scenarios

The Event

Event poster

Heart Failure 2026

10 May 2026 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Diastolic dysfunction and its association to renal outcomes in patients with chronic kidney disease
thumbnail
Congress Presentation
Prevalence and incidence of diastolic dysfunction in moderate aortic stenosis: clinical implication
thumbnail
Congress Presentation
Diastolic function in patients with preserved left ventricle ejection fraction: prognostic value and added role of left atrial strain

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources